Physician profile
Mark St Pierre
NPI 1730130956
$10,061.26
in general payments reported to CMS, 2019-2025
37 companies · $1,175 in 2025
The $1,175 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,411 · 2020: $973 · 2021: $1,355 · 2022: $1,525 · 2023: $1,494 · 2024: $1,128 · 2025: $1,175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,777 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,776.82 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,134.05 | 2019-2025 | |
| Medtronic, INC. | $996.67 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Azure Xt Dr Mri Surescan |
| Janssen Pharmaceuticals, INC | $762.03 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $622.37 | 2019-2025 | Farxiga |
| Pfizer INC. | $562.77 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $470.63 | 2021-2025 | Verquvo, Capvaxive |
| Sanofi-Aventis U.S. LLC | $454.05 | 2019-2024 | |
| Amgen INC. | $430.77 | 2019-2020 | |
| Abiomed | $408.69 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $404.58 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $400.84 | 2019-2024 | Jardiance |
| Boston Scientific Corporation | $341.91 | 2019-2025 | Avvigo Guidance System, Watchman |
| Astellas Pharma US INC | $233.49 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $192.04 | 2019-2024 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $180.00 | 2019-2025 | Uptravi, Opsumit |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $160.84 | 2019 | |
| Alnylam Pharmaceuticals INC. | $160.52 | 2022-2025 | Amvuttra, Onpattro |
| Abbott Laboratories | $155.50 | 2020-2024 | Cardiomems |
| E.R. Squibb & Sons, L.L.C. | $139.40 | 2019-2025 | Camzyos |
| Shockwave Medical, INC | $121.27 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $117.02 | 2019-2021 | |
| Baxter Healthcare | $91.13 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
| Bayer Healthcare Pharmaceuticals INC. | $88.73 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $75.98 | 2024 | Arcalyst |
| Innovation Technologies INC | $62.99 | 2025 | Irrisept |
| Gilead Sciences, INC. | $53.81 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $36.47 | 2024 | |
| Cardiovascular Systems INC. | $33.29 | 2022 | |
| Elutia, INC. | $25.19 | 2021 | |
| Kestra Medical Technology Services, INC. | $22.66 | 2025 | Assure Wcd |
| Genzyme Corporation | $22.55 | 2025 | |
| Lundbeck LLC | $20.56 | 2019 | |
| Glaxosmithkline, LLC. | $19.75 | 2025 | Shingrix |
| Novo Nordisk INC | $16.96 | 2023 | Ozempic, Rybelsus |
| Philips North America LLC | $15.19 | 2022 | |
| Bardy Diagnostics, INC. | $15.00 | 2022 | |
| Esperion Therapeutics, INC. | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark St Pierre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.